{"id":"W4392239323","doi":"10.51731/cjht.2024.842","title":"Polatuzumab Vedotin (Polivy)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Rituximab; Prednisone; Lymphoma; Internal medicine; Doxorubicin; Cyclophosphamide; Oncology; Chemotherapy; Political science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003786074,0.0002202726,0.0001979579,0.0006167315,0.000206725,0.0008212564,0.0003823655,0.0004904339,0.01525445],"category_scores_gemma":[0.0006649902,0.00008163632,0.0003095655,0.0004298784,0.0002834263,0.0003749162,0.0002606935,0.0005592006,0.003253622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002118388,"about_ca_system_score_gemma":0.002416787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01976253,"about_ca_topic_score_gemma":0.05236129,"domain_scores_codex":[0.9997972,0.00003492369,0.00001849922,0.00003280273,0.0000879661,0.00002863917],"domain_scores_gemma":[0.9997525,0.00004881687,0.00004820389,0.000009250126,0.0001006803,0.00004061421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000485304,0.00004912408,0.0008061894,0.001714783,0.00006989174,0.0002016109,0.00002701277,0.000170432,0.004565767,0.004306879,0.1442508,0.8433523],"study_design_scores_gemma":[0.0001858853,0.0002449046,0.002157763,0.0007536726,0.00005331752,0.0006956843,0.00001950552,0.0001055969,0.002696421,0.0003021579,0.9927776,0.000007560294],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01350638,0.6410448,0.00333387,0.01460838,0.003492057,0.0003516646,0.00326628,0.0005895134,0.3198071],"genre_scores_gemma":[0.2091834,0.516582,0.007287474,0.01934952,0.001086678,0.0002695665,0.006928847,0.00009864702,0.2392139],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01976253,"threshold_uncertainty_score":0.05103117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02382018295706657,"score_gpt":0.3022941830101228,"score_spread":0.2784740000530562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}